515 related articles for article (PubMed ID: 7509526)
1. Correlation of prostate-specific antigen and prostate-specific antigen density with outcome of prostate biopsy.
Bare R; Hart L; McCullough DL
Urology; 1994 Feb; 43(2):191-6. PubMed ID: 7509526
[TBL] [Abstract][Full Text] [Related]
2. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.
Men S; Cakar B; Conkbayir I; Hekimoglu B
J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539
[TBL] [Abstract][Full Text] [Related]
3. The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma.
Bretton PR; Evans WP; Borden JD; Castellanos RD
Cancer; 1994 Dec; 74(11):2991-5. PubMed ID: 7525040
[TBL] [Abstract][Full Text] [Related]
4. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations.
Gohji K; Nomi M; Egawa S; Morisue K; Takenaka A; Okamoto M; Ohori M; Fujii A
Cancer; 1997 May; 79(10):1969-76. PubMed ID: 9149025
[TBL] [Abstract][Full Text] [Related]
5. The usefulness of prostate-specific antigen (PSA) density in patients with intermediate serum PSA level in a country with low incidence of prostate cancer.
Yu HJ; Lai MK
Urology; 1998 May; 51(5A Suppl):125-30. PubMed ID: 9610567
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen density: a means to enhance detection of prostate cancer.
Ramon J; Boccon-Gibod L; Billebaud T; Astier L; Kobelinsky M; Meulemans A; Dauge MC; Boccon-Gibod L; Villers A
Eur Urol; 1994; 25(4):288-94; discussion 304. PubMed ID: 7519990
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific antigen density: correlation with histological diagnosis of prostate cancer, benign prostatic hyperplasia and prostatitis.
van Iersel MP; Witjes WP; de la Rosette JJ; Oosterhof GO
Br J Urol; 1995 Jul; 76(1):47-53. PubMed ID: 7544204
[TBL] [Abstract][Full Text] [Related]
8. An algorithm for prostate cancer detection in a patient population using prostate-specific antigen and prostate-specific antigen density.
Benson MC; McMahon DJ; Cooner WH; Olsson CA
World J Urol; 1993; 11(4):206-13. PubMed ID: 7508785
[TBL] [Abstract][Full Text] [Related]
9. The impact of prostate-specific antigen density in predicting prostate cancer when serum prostate-specific antigen levels are less than 10 ng/ml.
Akdas A; Tarcan T; Türkeri L; Cevik I; Biren T; Ilker Y
Eur Urol; 1996; 29(2):189-92. PubMed ID: 8647145
[TBL] [Abstract][Full Text] [Related]
10. [Early diagnosis of prostate carcinoma with reference to the density of prostate-specific antigen].
Schmid HP; Ravery V; Toublanc M; Boccon-Gibod L
Schweiz Med Wochenschr; 1996 Sep; 126(36):1530-5. PubMed ID: 8927956
[TBL] [Abstract][Full Text] [Related]
11. Rationale for using serum prostate-specific antigen (PSA) level and PSA density (PSAD) to detect prostatic malignancy in a country with low prostate cancer incidence.
Rahardjo D; Kamil ST; Pakasi LS
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():563-70. PubMed ID: 10895211
[TBL] [Abstract][Full Text] [Related]
12. Early detection of prostate cancer in men with prostatism and intermediate prostate-specific antigen levels.
Schmid HP; Ravery V; Billebaud T; Toublanc M; Boccon-Gibod LA; Hermieu JF; Delmas V; Boccon-Gibod L
Urology; 1996 May; 47(5):699-703. PubMed ID: 8650868
[TBL] [Abstract][Full Text] [Related]
13. The value of prostatic specific antigen density in the early diagnosis of prostate cancer.
Deliveliotis Ch; Louras G; Kyriazis P; Gyftopoulos A; Louka L; Alargof E
Int Urol Nephrol; 1998; 30(3):305-10. PubMed ID: 9696337
[TBL] [Abstract][Full Text] [Related]
14. [Systematic ultrasound guided transrectal core prostate biopsy based on serum level of prostate-specific antigen].
Yamaguchi S; Baba Y; Naito K
Hinyokika Kiyo; 1997 Sep; 43(9):641-5. PubMed ID: 9365843
[TBL] [Abstract][Full Text] [Related]
15. [Examination for indication of systematic biopsy for diagnosis of prostate cancer].
Muraoka K; Takahashi C; Yamamoto Y; Watanabe T; Hirakawa S; Miyagawa I
Nihon Hinyokika Gakkai Zasshi; 1999 Jul; 90(7):657-62. PubMed ID: 10481471
[TBL] [Abstract][Full Text] [Related]
16. Does prostate-specific antigen density alter decision making on biopsy?
Vleeming R; de Craen AJ; de Reijke TM; van Andel G; Kurth KH
Eur Urol; 1996; 29(1):10-14. PubMed ID: 8821683
[TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation of prostate-specific antigen density and systematic biopsies for early detection of prostatic carcinoma.
Bazinet M; Meshref AW; Trudel C; Aronson S; Péloquin F; Nachabe M; Bégin LR; Elhilali MM
Urology; 1994 Jan; 43(1):44-51; discussion 51-2. PubMed ID: 7506853
[TBL] [Abstract][Full Text] [Related]
18. [Predictive value of prostate specific antigen density in the detection of prostate cancer in patients with elevated prostate specific antigen levels and normal digital rectal findings or stage A prostate cancer].
Iwaki H; Kajita Y; Shimizu Y; Yamauchi T
Hinyokika Kiyo; 2001 Mar; 47(3):169-74. PubMed ID: 11329957
[TBL] [Abstract][Full Text] [Related]
19. Utility of volume adjusted prostate specific antigen density in the diagnosis of prostate cancer in Arab men.
Sheikh M; Al-Saeed O; Kehinde EO; Sinan T; Anim JT; Ali Y
Int Urol Nephrol; 2005; 37(4):721-6. PubMed ID: 16362587
[TBL] [Abstract][Full Text] [Related]
20. Cost-effective prostate cancer detection. Reduction of low-yield biopsies. Investigators of the American Cancer Society National Prostate Cancer Detection Project.
Littrup PJ; Kane RA; Mettlin CJ; Murphy GP; Lee F; Toi A; Badalament R; Babaian R
Cancer; 1994 Dec; 74(12):3146-58. PubMed ID: 7526969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
